IIPR Reports Q1 2026 Earnings with Revenue Growth and Strong Liquidity
IIPR reported Q1 2026 earnings with total revenues of $69 million, a 3.5% increase from Q4 2025, driven by payments from PharmaCann and Gold Flora settlements. The company also raised $128 million in capital year-to-date and maintained strong liquidity with $177 million at quarter-end. AFFO remained stable at $53.4 million.
Topics: capital raising financial performance leasing activity revenue growth